S.A. Mason’s Pediatrix Medical MD Stock Holding History

S.A. Mason’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$1K	–	350
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	379
2019 Q4	$3K	Buy	+100	New	+$2.51K	﹤0.01%	409

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

S.A. Mason's MD Position: Q2 2020 in Review

S.A. Mason sold out of Pediatrix Medical (MD) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

S.A. Mason first reported a position in MD in Q4 2019 and held it in 2 quarters. The position peaked at $3K in Q4 2019. 215 funds tracked by Wall St. Rank hold MD as of Q2 2020.

S.A. Mason reported no remaining Pediatrix Medical position as of Q2 2020 after selling out during the quarter.
S.A. Mason sold 100 Pediatrix Medical shares in Q2 2020, an estimated $1K.
S.A. Mason first reported a position in Pediatrix Medical in Q4 2019 and held it in 2 quarters.
S.A. Mason's Pediatrix Medical position peaked at $3K in Q4 2019.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2020.

Based on S.A. Mason's 13F filing for Q2 2020, filed 27 Jul 2020.